X-Med CBD Plus

X-Med CBD Plus is a high-CBD photoperiod strain developed from a high-CBD clone sourced from Switzerland and the USA, selected through rigorous phenotype screening to achieve a consistent 50:1 CBD to THC ratio. The cannabinoid profile sits at approximately 15% CBD and under 0.3% THC, making psychoactive effects negligible and therapeutic applications the primary focus. This Cannabis Sativa L.-based variety is naturally resilient, tolerating nutritional fluctuations and resisting insect pressure without significant intervention. It is well-adapted to outdoor cultivation, with average yields reaching around 500 grams per plant under good conditions — no specialized setup required. The flavor is fruity and herbal, with prominent grape and earthy notes providing a clean, pleasant experience. Beyond direct consumption, the rich terpene and phytocannabinoid profile makes this strain a viable source material for CBD cosmetic formulations and extracts. An uncomplicated, high-output CBD cultivar suited to outdoor growers and producers focused on therapeutic or cosmetic end-use applications.